T he regulated expression of specific integrins is a fundamental component of development, tissue homeostasis, and many diseases (1) . A prime example of this concept is the regulation of epithelial integrins, which function primarily in the anchoring of epithelial cells to laminins in the basement membrane (2) . Developmental and pathological processes that necessitate epithelial cell migration often involve disruption of the stable adhesive contacts provided by integrins (3) (4) (5) . The two major integrins that anchor epithelial cells to basement membrane laminins are ␣3␤1 and ␣6␤4 (6) (7) (8) (9) , and stimuli that disrupt epithelial adhesion frequently target the expression, localization, and cytoskeletal interactions of ␣6␤4 (3, 4, (10) (11) (12) . The epithelial-mesenchymal transition (EMT) provides a useful model system for studying the regulation of epithelial integrins. Although studies on the EMT have focused largely on mechanisms that disrupt cell-cell adhesions (13, 14) , disruption of integrin-mediated anchoring to matrix is an important component of the EMT, but the mechanisms involved are poorly understood.
The EMT of normal mammary epithelial cells involves transcriptional repression of the ␤4 integrin subunit (referred to as ␤4), which results in loss of the ␣6␤4 integrin (15) . This repression is associated with a decrease in active histone modifications (acetylation of histone H3 at K9 [H3K9Ac] and trimethylation of histone H3 at K4 [H3K4Me3]) and an increase in repressive histone modification (H3K27Me3) on the ␤4 promoter (15) . Although these previous observations provide a foundation for understanding how ␤4 is regulated during the EMT, little is known about the mechanisms involved. For example, are specific transcription factors involved in ␤4 repression, and, if so, what is their relationship to epigenetic modifications? Our pursuit of this problem in the current study revealed a key role for the zinc finger protein Snai1 in repressing ␤4. Interestingly, however, we observed that Snai1 is expressed in the nucleus of mammary epithelial cells, but it does not repress ␤4 transcription. This observation is consistent with other reports of Snai1 expression in epithelial cells (16) (17) (18) . Aside from the possibility that Snai1 can be excluded from the nucleus (19) , it is not known why nuclear Snai1 does not repress genes in epithelial cells. In an attempt to understand this paradox, we discovered that Snai1 interacts with Id2, and we dem-onstrate that Id2 constrains the repressive function of Snai1 by binding to its SNAG domain, a key domain for recruiting corepressors, including H3K27 methyltransferase (20) . Id2 is a helixloop-helix (HLH) protein family member that has been implicated as an antagonist of the EMT (21, 22) . Specifically, the EMT in several epithelial models is associated with strong suppression of Id2, and forced Id2 expression in mesenchymal cells is able to partially rescue an epithelial phenotype (21) . Given that Id2 can also impede the ability of Snai1 to repress E-cadherin, these findings provide insight into the regulation of epithelial genes, and they identify a novel mechanism for how Id2 maintains epithelial differentiation.
MATERIALS AND METHODS
Cell culture. NMuMG (normal murine mammary gland) cells were purchased from ATCC and maintained in complete medium containing Dulbecco's modified Eagle's medium (DMEM) (high glucose) with 10% fetal bovine serum, 10 g/ml insulin, 100 g/ml streptomycin, and 100 units/ml penicillin at 37°C in an incubator supplied with 5% CO 2 . Transforming growth factor ␤ (TGF-␤; Peprotech) was added directly into the culture medium at a final concentration of 4 ng/ml for the time periods indicated in the figure legends. For long-term (more than 2 days) treatment with TGF-␤ (EMT), cells were passed into fresh complete medium containing 4 ng/ml TGF-␤. For the TGF-␤ withdrawal experiments, cells that had undergone EMT in the presence of TGF-␤ were passed into fresh complete medium without TGF-␤. MCF7 cells were purchased from ATCC and maintained in the DMEM (low glucose) containing 10% fetal bovine serum, 100 g/ml streptomycin, and 100 units/ml penicillin at 37°C in an incubator supplied with 5% CO 2 .
Microarray analysis.
A Qiagen RNeasy minikit was used to extract total RNA from untreated epithelial NMuMG cells (EPTH), NMuMG cells treated with TGF-␤ for 11 days (EMT), and NMuMG cells treated with TGF-␤ for 11 days followed by TGF-␤ withdrawal for 13 days (mesenchymal-epithelial transition [MET] ). For each sample, 500 ng of total RNA with poly(A) RNA control stock was used to synthesize the biotinlabeled antisense RNA (aRNA), following the protocol described in the manual of the Affymetrix 3= IVT Express Kit (23) . The aRNA was then purified using aRNA-binding magnetic beads and fragmented to a size range of 90 to 110 nucleotides (nt). The purified aRNA (15 g) was used to hybridize with the Mouse Genome 430 2.0 Array (Affymetrix). All samples were run in duplicate. Analyses were performed using BRB-Ar-rayTools developed by Richard Simon and the BRB-ArrayTools Development Team (24) . The raw array data were normalized using the robust multiarray average (RMA) algorithm. The three sample groups described above were subjected to class comparison, and genes that were differentially expressed are summarized in the Venn diagram shown in Fig. S1A in the supplemental material. Genes that exhibited less than a 2-fold change or a P value of Ͼ0.001 were excluded from the data summary presented.
Biochemical techniques. For quantitative, real-time PCR (qPCR), total RNA was extracted using TRIzol reagent (Invitrogen), and cDNAs were produced using Superscript II (Invitrogen) according to the manufacturer's instructions. qPCR was performed using a SYBR green master mix (Applied Biosystems). The qPCR primers used are provided in Table  S1 in the supplemental material. Two-tailed Student t tests were used for statistical comparison. Immunoblotting was performed as described previously (25) using antibodies (Abs) for the following: ␤4 (505) (11), actin (A20660; Sigma), E-cadherin (334000; Invitrogen), Id2 (C-20; Santa Cruz Biotechnology), Id1 (C-20; Santa Cruz Biotechnology), Snai1 (L70G2; Cell Signaling), Pol2 (8WG16; Covance), Flag (M2; Sigma), and hemagglutinin (HA) (clone 3F10; Roche). Densitometry of the immunoblots was performed using Gel-pro Analyzer, version 4.0.
The nuclear fraction assay used is described in the Abcam protocol database (http://www.abcam.com/index.html?pageconfigϭresource&rid ϭ11408). Briefly, cells were extracted using buffer A (10 mM HEPES, 1.5 mM MgCl 2 , 10 mM KCl, 0.5 mM dithiothreitol [DTT], 0.05% NP-40, pH 7.9) and centrifuged at 800 ϫ g at 4°C for 10 min. The supernatant from this extract was saved as the cytoplasmic fraction. The remaining pellets were Dounce homogenized, extracted using buffer B (5 mM HEPES, 1.5 mM MgCl 2 , 0.2 mM EDTA, 0.5 mM DTT, 26% glycerol [vol/vol], pH 7.9) containing 300 mM NaCl and centrifuged at 16,100 ϫ g for 20 min at 4°C. The supernatant from this extraction was saved as the nuclear fraction.
For the coimmunoprecipitation (co-IP) experiments, cell extracts were prepared using NP-40 or Triton lysis buffer (Boston BioProduct) containing protease inhibitor cocktail (Roche). Extracts were precleared using a 50% protein G suspension (Biovision). For each IP, 200 to 500 g of total protein was incubated with 40 l of anti-Flag (M2) bead slurry (Sigma) at 4°C overnight in the appropriate lysis buffer. In some experiments, total protein was incubated with 1 g of antibody overnight at 4°C first and then subjected to bead enrichment by 40 l of 50% protein G slurry (Biovision) for another 1 to 2 h at 4°C. Subsequently, beads were washed with 1 ml of cold IP lysis buffer, and immunoprecipitated fractions were extracted by boiling in 2ϫ SDS loading buffer (Boston Bioproducts). Samples were then resolved by SDS-PAGE and immunoblotted. IP antibodies were Snai1 Ab1 (L70G2; Cell Signaling), Snai1 Ab2 (G-7; Santa Cruz Biotechnology), and HA (clone 3F10; Roche).
Constructs, transfections, and RNA interference. pCMX-based expression constructs including HA alone, HA-Snai1 (mouse), or Flag-Id2 (mouse) were inserted between the KpnI-BamHI sites of the pCMX vector. PT7CFE1-based expression constructs, PT7CFE1-Id2 and PT7CFE-Id1 (mouse), were cloned between NdeI and NotI sites of the PT7CFE1-CHis vector (Thermo Fisher Scientific). To construct the luciferase reporter for the ␤4 promoter, promoter fragments from Ϫ1572 to ϩ254 were amplified by PCR using a KOD high-fidelity DNA polymerase kit (Novagen). Each fragment was gel purified by a Qiagen gel extraction kit, digested with restriction enzymes (NEB), and inserted between the NheI and HindIII sites into the pGL3-basic vector (Promega). All constructs were confirmed by sequencing analysis (Genewiz).
Retrovirus-mediated expression in NMuMG cells was performed using the MSCV-IRES-GFP vector (where MSCV is murine stem cell virus, IRES is internal ribosome entry site, and GFP is green fluorescent protein) (plasmid 9044 [Addgene], also termed pMIG), and stable expression was confirmed by assessing GFP-positive cells, which comprised 90 to 100% of the cell population. The full-length Snai1 (mouse) open reading frame (ORF) was PCR amplified from the total cDNA of NMuMG cells and ligated into pMIG. To construct Snai1-⌬SNAG, the Snai1 (mouse) ORF lacking the 4th to 60th nucleotides was generated by PCR and ligated into pMIG. An HA tag was added on the 3= end of Snai1 or the Snai1-⌬SNAG ORF to produce Snai1-HA or Snai1-⌬SNAG-HA. All cDNAs were inserted between XhoI and NotI sites of pMIG.
To construct glutathione S-transferase (GST)-SNAG and GST-Snai1, the SNAG domain (nt 1 to 60 of Mus Snai1) or the full-length Snai1 (mouse) ORF was cloned into the EcoRI site of the PGEX4T-1 vector (GE Healthcare). For GST-Id2, the full-length Id2 ORF was PCR amplified and then cloned into the pGEX-4T-1 vector with BamHI/SalI restriction sites. All constructs were confirmed by sequencing analysis (Genewiz).
The inducible system using an estrogen receptor (ER) fusion protein has been described previously (26) (27) (28) . The retroviral Snai1-ER expression construct, PWZL-Snai1-ER (referred to as Snail-ER), was provided by Karl Simin (University of Massachusetts Medical School). The construction of the vector is described elsewhere (29) . NMuMG cells infected by Snai1-ER virus were selected by blasticidin (6 g/ml) for 7 days. All of the blasticidin-resistant NMuMG cells with Snai1-ER stable integration were then treated with medium containing 250 nM 4-hydroxytamoxifen (4-OHT) for Snai1 activation or an equal volume of ethanol (the solvent of 4-OHT) as a control for 7 days prior to protein analysis.
The constructs expressing the short hairpin RNA (shRNA) targeting Snai1 (shSnai1) were generated using Psuperior-Neo retroviral vector (Oligoengine). The shRNA targeting sequences are GGGAGAAAGATGT TTACAT (shSnai1-2) and CACCTTCTTTGAGGTACAA (shSnai1-3). Stable expression of these shRNAs in the NMuMG cells was obtained by G418 (1 mg/ml) selection for 7 days after retroviral infection, using shGFP as a nontargeting control. The mouse and human shId2 expression constructs used in this study were purchased from Open Biosystems, and the reference numbers are as follows: mouse shId2-1, TRCN0000054390, and shId-2, TRCN0000054391; human shId2-1, TRCN0000021064, and shId2-2, TRCN0000021065. Stable expression of these pLKO-based vectors in NMuMG cells was obtained by puromycin (2 g/ml) selection for 5 to 6 days, using shGFP as a nontargeting control.
ChIP. Chromatin immunoprecipitation (ChIP) assays were performed using a ChIP-it Express Kit (catalog number 53008; Active Motif) with minor modifications according to Tian et al. (30) . Cells were first cross-linked with 2 mM disuccinimidyl glutarate (catalog number c1104; Proteochem) for 45 min at room temperature (RT) and then washed and subjected to cross-linking by 1% formaldehyde (Sigma) for 15 min at RT. The reaction was quenched using 125 mM glycine for 5 min. Subsequently, the cells were washed with phosphate-buffered saline (PBS), scraped from the plate, and lysed in 1 ml of lysis buffer [5 mM piperazine-N,N=-bis(2-ethanesulfonic acid) (PIPES; pH 8.0), 85 mM KCl, 0.5% NP-40, and protease inhibitor]. Nuclear pellets were lysed again with nuclear fraction buffer (50 mM Tris-HCl, 10 mM EDTA, 1% SDS, pH 8.0, and protease inhibitor) and resuspended in 400 l of ChIP buffer (150 mM NaCl, 50 mM Tris-HCl, 1 mM EDTA, 1% Triton X-100, 0.1% sodium deoxycholate, 0.1% SDS with protease inhibitor). Chromatin was then subjected to sonication using a Sonicator 3000 (Misonix, Inc.) for four cycles of 20-s (power setting, 2.0) bursts to generate chromatin fragments that ranged from 200 to 700 bp. The sonicated chromatin samples were then used in the ChIP assay according to the protocol of the kit. Each ChIP sample contained chromatin from 1 ϫ 10 6 to 2 ϫ 10 6 cells and 2 g of Ab. For ChIP, antibodies for the following were used: H3K27Me3 (07-449; Millipore), H3K4Me3 (05-1339; Millipore), H3K9Me3 (07-442; Millipore), and H3 (2650; Cell signaling). Snai1 ChIP-grade Ab was a kind gift of A. de Herreros (31); Id2 (clone C-20; Santa Cruz Biotechnology) or isogenic IgG was used. ChIP incubation was performed overnight (15 h to 16.5 h) at 4°C. The immunoprecipitated DNA was then subjected to realtime PCR analysis using ChIP primers targeting different regions of the ␤4 promoter. Primer sets for ChIP PCR on the ␤4 promoter are provided in Table S1 in the supplemental material. Two-tailed Student t tests were used for statistical comparison.
Immunofluorescence microscopy. Immunofluorescence microscopy was performed as described previously (10) using Snai1 Ab (1:50 dilution) (L70G2; Cell Signaling) and Id2 Ab (1:200 dilution) (C-20; Santa Cruz Biotechnology), anti-mouse tetramethyl rhodamine isocyanate (TRITC) secondary Ab (1:250 dilution) (15-025-150; Jackson Im-munoResearch) and anti-rabbit fluorescein isothiocyanate (FITC)-secondary Ab (1:250 dilution) (711-096-152; Jackson ImmunoResearch). The microscope was made by Zeiss (model LSM-700), and the pictures were taken using the camera of an Axio Imager Z2 at room temperature (23°C). A 40ϫ oil immersion objective with a numerical aperture of 1.30 was used. The pictures were analyzed and exported using ZEN 2011 and processed using Adobe Photoshop.
Luciferase reporter assays. NMuMG cells were grown in 24-well plates and transiently transfected with 0.5 g of each reporter construct and 0.1 g of Renilla luciferase using 2 l of Lipofectamine 2000 in 100 l of Opti-MEM mix for each well. Luciferase assays were performed using a Dual-Luciferase reporter assay System (Promega). All experiments were performed in triplicate. Promoter activity was reported as the average of the ratio of firefly luciferase to Renilla luciferase. Two-tailed Student t tests were used for statistical comparison.
GST pulldown experiments. The methods for GST purification and the GST pulldown assay have been described elsewhere (32) . Briefly, GST constructs were expressed in Escherichia coli strains JM109 or BL21(DE3) with isopropyl-␤-D-thiogalactopyranoside (IPTG; 100 M) stimulation for 3 h at 37°C. Cells were then lysed, and the GST fusion proteins were purified using glutathione-Sepharose 4B (Bioworld). The molecular mass of the purified GST fusion protein was confirmed by SDS-PAGE. In vitro Numbers below the blots indicate relative intensity of the bands based on densitometry (same as below). (B) Expression of ␤4 and E-cadherin mRNAs was quantified by qPCR in the same populations as described in panel A. *, P Ͻ 0.05. (C to E) Snai1 cDNA or empty vector was expressed in NMuMG cells, and the expression of ␤4, E-cadherin, Snai1, and actin was evaluated by immunoblotting (C), and ␤4 mRNA expression was quantified by qPCR (D) (*, P Ͻ 0.05). The relative luciferase activity of the ␤4 promoter in the control and Snai1-expressing cells was determined (E) (*, P Ͻ 0.05). (F) Snai1 expression in NMuMG cells was stably diminished using two independent shRNAs, and the effect was quantified by qPCR. (G) The control and Snai1 knockdown cells described in panel F were treated with either carrier (EPTH) or TGF-␤ (EMT) for 2 days to induce an EMT, and the expression of ␤4, Snai1, and actin was assessed by immunoblotting (G). (H) The expression of ␤4 mRNA in the control or shSnai1 NMuMG cells with the same treatment as described in panel G was quantified by qPCR (*, P Ͻ 0.05). Numbers on the left of the blots indicate the size (in kilodaltons) of the protein standard.
translation of Id1, Id2, and Snai1 was performed using a 1-Step Human In Vitro protein expression kit (ThermoFisher Scientific). The translated lysates were then precleared using 5 l of a 50% suspension of GST beads prior to GST pulldown. Equal amounts of the GST fusion protein bead suspension were mixed with the in vitro translated lysates in the lysis buffer (20 mM Tris-HCl, pH 8.0, 200 mM NaCl, 1 mM EDTA, 0.5% NP-40, and protease inhibitor) with a total volume of 500 l. After 2 h of incubation at 4°C, the beads were washed four times with 1 ml of cold lysis buffer. Samples were resolved by SDS-PAGE and subjected to radioautography or immunoblotting. In vitro translated lysates (10 to 12%) were used as input.
Microarray data accession number. The microarray data have been deposited in the Gene Expression Omnibus (GEO) database under accession number GSE48204. 
RESULTS AND DISCUSSION
Snai1 represses integrin ␤4 transcription. The normal murine mammary gland cell line (NMuMG) undergoes a bona fide EMT in response to TGF-␤, and subsequent TGF-␤ withdrawal results in a mesenchymal-epithelial transition (MET) (15, 33) . To screen for potential factors that could repress ␤4 transcription, we compared the gene expression profiles of epithelial NMuMG cells (EPTH), TGF-␤-treated NMuMG cells (EMT), and TGF-␤ treated/TGF-␤ withdrawn NMuMG cells (MET) (see Fig. S1A in the supplemental material). Among the potential EMT-promoting transcription factors, only Snai1 exhibited significant induction during EMT and reduction during MET (GEO accession number GSE48204). Given that Snai1 can repress several epithelial genes including E-cadherin (18, (34) (35) (36) (37) , we assessed whether it could repress ␤4. For this purpose, we used an inducible system in which a human Snai1 cDNA was fused with an estrogen receptor (ER) construct (29) . This Snai1-ER construct was stably expressed in NMuMG cells, enabling Snai1 function to be activated in the presence of 4-hydroxytamoxifen (4-OHT). Activation of Snai1 activity repressed ␤4 protein and mRNA expression significantly ( Fig. 1A and B ). Note that 4-OHT itself had minimal effect on ␤4 expression and transcription in control cells. Expression of a mouse Snai1 cDNA in NMuMG cells also repressed ␤4 expression and transcription (Fig. 1C, D , and E). Snai1 also repressed E-cadherin expression (Fig. 1C) , consistent with previous data (35, 36) . Conversely, we diminished Snai1 expression using two independent shRNAs ( Fig. 1F) and observed a rescue of ␤4 protein (Fig. 1G ) and mRNA expression ( Fig. 1H ) in TGF-␤-treated cells. Taken together, these data indicate that Snai1 represses ␤4 and is responsible for the loss of ␤4 during TGF-␤-induced EMT. Snai1 induces the repressive histone mark H3K27Me3 on ␤4 promoter. Snai1 is known to modify the histone marks on the promoter of its target genes, including demethylation of H3K4 (38) and deacetylation of H3/H4 (39), as well as methylation of H3K27 (20) , H3K9 (40, 41) , and H4R3 (42) . We chose to focus on the Polycomb complex-associated repressive mark, H3K27Me3, as a proof of principle for the function of Snai1 because our earlier study established that the increase of this mark is concomitant with the repression of ␤4 (15) . Indeed, ectopic expression of Snai1 significantly increased the H3K27Me3 histone modification but not H3K9Me3 (see Fig. S1B in the supplemental material) on the ␤4 promoter, as evidenced by chromatin immunoprecipitation (ChIP) ( Fig. 2A, left) . This approach also demonstrated that Snai1 binds specifically to an E box that is located shortly after the transcription start site of the ␤4 promoter, designated E5 ( Fig. 2A,  right , and E, bottom for a schematic of the ␤4 promoter). Note that E5 is the only E box in the ␤4 promoter that is conserved across species (see Fig. S1C ).
Snai1 is not functional in epithelial NMuMG cells. We detected Snai1 expression in epithelial NMuMG cells (Fig. 2B) and found that it is localized in the nucleus (Fig. 2C and D) . This observation prompted us to use ChIP to assess the binding pattern of endogenous Snai1 on the ␤4 promoter in epithelial cells and compare it to EMT cells. Snai1 binds to the E5 in both epithelial and EMT cells ( Fig. 2E ). However, it does not repress ␤4 in epithelial NMuMG cells (Fig. 2B ). Based on this observation, we speculated that an adaptor protein impedes the repressive function of Snai1 on E5. Id2 captured our attention for several reasons. Our microarray analysis (accession number GSE48204) revealed that it is the most repressed gene during the EMT. Moreover, Id2 localized in both the nucleus and cytoplasm of epithelial cells (Fig.  2C) , and its expression is depleted during the EMT (Fig. 2F and  G) . Id1 expression is also diminished during the EMT (Fig. 2G) , but it has been reported to facilitate the EMT (43, 44) . Interestingly, Id3 expression increases during the EMT (Fig. 2G ).
Id2 and Snai1 form a complex. Although Id2 can interact with retinoblastoma protein (Rb) and basic HLH (bHLH) proteins (45) (46) (47) , there is no evidence that it can complex with zinc finger proteins. To test the possibility that Snai1 partners with Id2, we performed coimmunoprecipitation assays and found that Id2 coimmunopurifies with Snai1 in vitro (Fig. 3A) and in vivo (Fig. 3B) . Moreover, GST pulldown assays using Id2 as bait confirmed that this interaction is direct (Fig. 3C) . These biochemical interactions were substantiated by the observation that Id2 and Snai1 colocalize in a punctate structure within the nuclei of epithelial NMuMG cells (Fig. 3D ). Furthermore, ChIP experiments revealed that Id2 binds to the same locus (E5) of the ␤4 promoter as Snai1 does, and the binding is lost during the EMT (Fig. 3E) . Importantly, knockdown of Snai1 diminished this specific enrichment of Id2 on the ␤4 promoter ( Fig. 3F and G) . Given that Id2 cannot bind DNA directly (45) , these results indicate that an Snai1-Id2 complex binds to the ␤4 promoter in epithelial NMuMG cells.
Loss of Id2 diminishes ␤4 and E-cadherin expression. The finding that Id2 complexes with Snai1 in epithelial cells and that Snai1 does not repress ␤4 expression in these cells suggested that Id2 compromises the repressive function of Snai1. To disrupt this complex, we depleted Id2 by two independent shRNAs in epithelial cells and assessed ␤4 expression. Silencing Id2 resulted in de- creased ␤4 mRNA and protein expression compared to levels in control cells (Fig. 4A and B) . Importantly, knockdown of Snai1 in the Id2-silenced cells completely rescued the expression of ␤4 mRNA and protein, indicating that the repression of ␤4 that occurs in response to Id2 loss is Snai1 dependent (Fig. 4C and D) . Similar results were obtained for E-cadherin, an established target of Snai1 (Fig. 4A, C, and D) . Taken together, these data reveal that Id2 restrains Snai1 from its ability to repress epithelial genes.
Id2 masks the SNAG domain of Snai1 and prevents the H3K27Me3 repressive mark. The SNAG domain is crucial for the repressive function of Snai1 because it mediates the interaction of Snai1 with many corepressors (20, 38, 39, 41) . This finding is consistent with our data that deletion of this domain abrogated the ability of Snai1 to repress ␤4 expression ( Fig. 5A ). Moreover, a ⌬SNAG mutant of Snai1 functions as a dominant negative mutant that rescues ␤4 expression in NMuMG cells engineered to express Snai1 (Fig. 5B) . Given the importance of this domain and our observation that Id2 inhibits the function of Snai1 via a complex formation, the possibility emerged that the Id2-Snai1 interaction is mediated through the SNAG domain of Snai1. Indeed, HA- Snai1 coimmunopurified with Id2, but the HA-⌬SNAG mutant failed to do so (Fig. 5C ), demonstrating that SNAG is essential for the Id2-Snai1 interaction. Moreover, we confirmed that the SNAG domain itself is sufficient to bind Id2 directly using a GSTpulldown approach, in which the GST-SNAG domain fusion protein was used as bait for Id2 (Fig. 5D ). Considering that Id1 is also repressed by the EMT (Fig. 2G) , we also examined the potential interaction between Id1 and Snai1 in the same setting. Although Id1 and Snai1 can interact, the interaction is 4-to 6-fold weaker than the interaction between Id2 and Snai1 ( Fig. 5C and D) . This finding indicates that that Id2 is a dominant interacting partner of Snai1 when both Id1 and Id2 are expressed.
Our data indicate that Id2 can mask the SNAG domain, which should result in the failure of Snai1 to establish H3K27Me3. Indeed, knockdown of Id2 in epithelial NMuMG cells caused a significant elevation of this repressive histone mark (Fig. 5E ). We also assessed whether Id2-Snai1-mediated regulation of ␤4 occurs in other epithelial cells. Specifically, MCF7 cells are well-differentiated carcinoma cells that express ␤4, Id2, and Snai1 ( Fig. 5F and G). Importantly, endogenous Snai1 is localized in the nucleus of these cells (Fig. 5F ), and knockdown of Id2 caused a reduction of ␤4 expression ( Fig. 5G) .
A major conclusion of our study is that Snai1 can be expressed in the nucleus of epithelial cells and bind to specific promoters, but its ability to repress transcription is restrained by its association with Id2 ( Fig. 6 ). More specifically, we demonstrate that the repressive function of Snai1 is compromised by the interaction of its SNAG domain with Id2. To our knowledge, this is the first identification of a functional antagonist that binds the SNAG domain of Snai1 in the epithelial cells. In previous studies, the SNAG domain was shown to be essential for recruiting several cooperative cofactors that are necessary for removing active histone marks and adding repressive ones, including Suz12 (20) , Suv39H1 (41), LSD1 (38), HDAC1/2 (39) , and Ezh2 (48) . Based on our observation that the repressive mark H3K27Me3, but not H3K9Me3, is elevated in response to Id2 loss, it is possible that the corepressor responsible for H3K27Me3, Ezh2, is unable to bind Snai1 in the presence of Id2. We pursued this possibility experimentally, but the data generated did not enable a definitive conclusion.
The ability of Id2 to complex with the zinc finger protein Snai1 provides a novel mechanism accounting for the role of Id2 in the EMT. It is known that Id2 is repressed dramatically in epithelial cells by TGF-␤ signaling and that forced expression of Id2 rescues epithelial gene expression in TGF-␤-treated cells (21) . The ability of Id2 to bind and sequester E2A, a basic helix-loop-helix protein, from binding target genes including E-cadherin has been proposed as a mechanism to account for these observations (22) . Our finding that Id2 complexes with Snai1 on the promoter of the target gene and prevents Snai1 from recruiting transcriptional corepressors provides a distinct mechanism for how Id2 contributes to epithelial differentiation. Collectively, the existing data substantiate the potency of Snai1 in promoting a mesenchymal transition and its need to be regulated. Our finding that Id1 can also interact with Snai1 suggests that this interaction may involve the HLH domain. Given that the interaction with Id2 is much stronger than Id2, Id2-specific domains may also be involved in Id2-Snai1 association.
The data reported here expand and complement other studies on the repression of ␤4 and other epithelial genes. Snail has a preeminent role in the repression of ␤4 ( Fig. 1 ) and E-cadherin (36) , but several other factors contribute to this repression, including Twist, Slug, and Zeb1 (13) . For example, based on the findings that Zeb1 represses ␤4 transcription (49) and that Snai1 induces Zeb1 expression (50), we infer that ␤4 transcriptional repression involves a cascade of Snai1-and Zeb1-mediated events and that Id2 functions upstream to prevent the initiation of this cascade by complexing with the SNAG domain of Snai1. This hypothesis is supported by the observation that Id2 overexpression in TGF-␤-treated epithelial cells suppressed Zeb1 induction (51) . In a different direction, we reported that ␤4 repression during the EMT is associated with promoter methylation (15) , and it is known that Snai1 can mediate DNA methylation (40) . Although these observations suggest that methylation of the ␤4 promoter should increase in response to Id2 loss, we did not detect such an increase (data not shown). Most likely, this observation indicates that additional factors are required for de novo methylation, such as DNMT3s (52) .
The mechanistic relationship between Id2 and ␤4 is foreshadowed by other studies that support our central hypothesis. Of note, the progenitor population of lung epithelial cells is enriched in both Id2 and ␤4 expression (53, 54) , suggesting that Id2 may facilitate the purported role of ␤4 in the function of lung epithelial stem cells (55) . Our data may also have significant implications for the regulation of ␤4 in cancer. For example, nuclear Id2 expression correlates significantly with a poor prognosis in non-smallcell lung carcinoma (56) , and ␤4 expression is also upregulated in these carcinomas (57) . Clearly, Id2-mediated regulation of ␤4 expression merits further investigation, especially in the context of metastasis, which involves a reversion to an epithelial phenotype and increased expression of ␤4 (58). 
